Landec Corporation (LNDC) : Signia Capital Management has sold out all of its stake in Landec Corporation during the most recent quarter, according to the disclosure filed by the company on Aug 3, 2016 with the SEC. The investment management company has sold out 22,549 shares of Landec Corporation which is valued at $264,274.
Other Hedge Funds, Including , Palouse Capital Management reduced its stake in LNDC by selling 390 shares or 2.6% in the most recent quarter. The Hedge Fund company now holds 14,596 shares of LNDC which is valued at $169,606. Landec Corporation makes up approx 0.07% of Palouse Capital Management’s portfolio.Foundry Partners boosted its stake in LNDC in the latest quarter, The investment management firm added 80,110 additional shares and now holds a total of 263,075 shares of Landec Corporation which is valued at $2,856,995. Landec Corporation makes up approx 0.27% of Foundry Partners’s portfolio.
Landec Corporation opened for trading at $12.01 and hit $12.24 on the upside on Monday, eventually ending the session at $12.19, with a gain of 1.25% or 0.15 points. The heightened volatility saw the trading volume jump to 45,792 shares. Company has a market cap of $332 M.
On the company’s financial health, Landec Corporation reported $0.01 EPS for the quarter, missing the analyst consensus estimate by $ -0.02 based on the information available during the earnings call on Mar 29, 2016. Analyst had a consensus of $0.03. The company had revenue of $129.99 million for the quarter, compared to analysts expectations of $136.96 million. The company’s revenue was down -6.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.14 EPS.
Many Wall Street Analysts have commented on Landec Corporation. Wedbush Initiated Landec Corporation on Jul 8, 2016 to “Neutral”, Price Target of the shares are set at $12.Maxim Group Initiated Landec Corporation on Jun 7, 2016 to “Buy”, Price Target of the shares are set at $16.
Landec Corporation designs develops manufactures and sells differentiated products for food and biomaterials markets and licenses technology applications to partners. The Company’s segments include Food Products Technology Food Export and Hyaluronan-based Biomaterials. The Company’s Food Products Technology segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables. The Company’s Food Export segment is engaged in the purchase and sale of whole commodity fruit and vegetable products to Asia and domestically. The Company’s Hyaluronan-based Biomaterials segment sells products utilizing hyaluronan a polysaccharide that is distributed in the extracellular matrix of connective tissues in both animals and humans for medical use primarily in the ophthalmic orthopedic and veterinary markets. The Company licenses its Intellicoat seed coatings to the farming industry and licenses its Intelimer polymers for personal care products and other industrial products.